A randomised phase II study of continuous versus stop-and-go S-1 plus oxaliplatin following disease stabilisation in first-line chemotherapy in patients with metastatic gastric cancer
Keyword(s):
Phase Ii
◽
2018 ◽
Vol 28
(1)
◽
pp. 23-30
◽